US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

1  2  3    5    7  8  9  10  
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor 1 (FGF-1) Inhibitors. This report provides information on the therapeutic development based on the Fibroblast Growth ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
Analytical Instrumentation & Systems (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... both a written and graphical analysis – analysing the 40 largest Analytical Instrumentation & Systems (UK) companies. The Analytical Instrumentation & Systems (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to ...  |  read more...
USD 560
Instrumentation Engineers (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 80 largest Instrumentation Engineers (UK) companies. The Instrumentation Engineers (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Biotechnology (Pharmaceuticals) (Global) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... the 120 largest Biotechnology (UK) companies. The Biotechnology (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises the market ...  |  read more...
USD 1,520
Medical & Scientific Research (Global) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 500 largest Medical & Scientific Research (Global) companies. The Medical & Scientific Research (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,520
Starch Manufacturers (Global) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 100 largest Starch Manufacturers (Global) companies. The Starch Manufacturers (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section ...  |  read more...
USD 1,520
Biotechnology (Nordic) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... the 270 largest Biotechnology (Nordic) companies. The Biotechnology (Nordic) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises the market ...  |  read more...
USD 1,000
Interferon Receptor Binders -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Interferon Receptor Binders. This report provides information on the therapeutic development based on the Interferon Receptor Binders dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Cleveland Biolabs, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Cleveland Biolabs, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Charles River Laboratories International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Charles River Laboratories International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership ...  |  read more...
USD 350
Next Generation Sequencing (NGS) Global market - Forecast to 2020
11/6/2014 | published by: IQ4I Research and Consultancy
... introduction as Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was sequenced, ...  |  read more...
USD 4,500
Stem Cells Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Stem Cells in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 900
Proteins in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 85 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 162 drug targets that are included ...  |  read more...
USD 6,746
Arcadia Biosciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Arcadia Biosciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Global Cardiac Biomarkers Market 2014-2018
11/5/2014 | published by: TechNavio - Infiniti Research Ltd.
... as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, ...  |  read more...
USD 3,000
Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture ...  |  read more...
USD 350
KINAXO Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' KINAXO Biotechnologies GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
WaferGen Bio-systems, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Genetic Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Genetic Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ...  |  read more...
USD 350
Cell Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Cell Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
TiGenix N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' TiGenix N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
1  2  3    5    7  8  9  10